<DOC>
	<DOCNO>NCT00386555</DOCNO>
	<brief_summary>To determine effectiveness CP-868,596 + docetaxel , AG-013736 + docetaxel CP-868,596 + AG-013736 + docetaxel patient previously treat non-small cell lung cancer .</brief_summary>
	<brief_title>A Phase 2 Study Patients With Advanced Non-Small Cell Lung Cancer Using New Agents With Without Docetaxel .</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Crenolanib</mesh_term>
	<mesh_term>Axitinib</mesh_term>
	<criteria>Platinumpretreated patient advanced stage IIIb IV NSCLC Centrallylocated tumor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
</DOC>